Medical Device | May 20, 2022
Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series
ASC22 (Envafolimab) is a subcutaneously administered single-domain antibody against PD-L1 and has the potential to restore virus-specific immune responses in patients with chronic viral infection
NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
It signals Cordis' renewed investment in innovation
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
This has further strengthened its manufacturing presence in the United States of America
Modi holds a bachelor's degree in Chemical Engineering from University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management
Subscribe To Our Newsletter & Stay Updated
